Examining Combination Therapies for Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
The screen goes blue, that unmistakable tune starts playing, and the voice of Johnny Gilbert announces, “This. Is. Jeopardy!” We meet the contestants. We hear...
In 2019, Michael D. Story, PhD, vice chair of the Department of Radiation Oncology and chief of the Division of Molecular Radiation Biology at UT Southwestern Medical Center, was one of...
For September, the editors of the nine AACR journals have chosen to highlight a clinical trial that evaluated an Hsp90 inhibitor for...
September is Childhood Cancer Awareness Month. Childhood cancer is relatively rare, but it is a devastating diagnosis that can...
Every September 24, World Cancer Research Day provides an opportunity to raise awareness about the important role research plays...
The American Association for Cancer Research (AACR) released its annual Cancer Progress Report today. The report serves as an important record of the...
Supreme Court Justice Ruth Bader Ginsburg is not among us today. Sadly, we lost this iconic, trailblazing leader, who was the...
Lymphomas are a form of blood cancer that begin in lymphocytes, also known as white blood cells. Over the...